Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 7/2016

01-07-2016 | Original Article – Cancer Research

Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration

Authors: Yoshitaka Suda, Shinya Neri, Hiroko Hashimoto, Youichi Higuchi, Masayuki Ishibashi, Masato Sugano, Kenkichi Masutomi, Masahiro Tsuboi, Atsushi Ochiai, Genichiro Ishii

Published in: Journal of Cancer Research and Clinical Oncology | Issue 7/2016

Login to get access

Abstract

Background

Cancer-associated fibroblasts (CAFs) consist of heterogeneous cell population in terms of their differentiation potential. The functional differences in tumor progression between CAFs with mesenchymal stem/progenitor cells (MSCs/MPCs) characteristics and CAFs without MSCs/MPCs characteristics are not clarified.

Methods

CAFs and vascular adventitial fibroblasts (VAFs, which contain MSCs/MPCs) were isolated from nine primary lung cancers and were cultured in osteogenic or adipogenic medium to assess their multi-lineage differentiation. Next, we established nine single-cell-derived clones from the primary culture of CAFs and examined their differentiation potential. The effects of each single-cell-derived clone on the proliferation and migration of lung adenocarcinoma cell line, A549, were analyzed.

Results

The nine samples of VAFs and CAFs showed various degrees of osteogenic differentiation. Although the VAFs displayed the ability to undergo adipogenic differentiation, all cases of the CAFs did not. CAFs clones presented varying degrees of osteogenic differentiation. Four clones displayed comparable levels of osteogenic potential with that of the VAFs, and two clones were completely negative. As compared to the CAFs clones that possessed lower osteogenic potential, CAFs clones with higher osteogenic potential did not confer proliferative activity in A549 cells. On the contrary, these clones significantly promoted the migration of A549 cells as compared to the clones with lower osteogenic potential.

Conclusion

Our studies clearly indicate that CAFs derived from lung cancer are heterogeneous population that consists of cells with varying osteogenic potentials and that CAFs with higher osteogenic potential have a greater tumor-promoting function through the enhancement of cancer cell migration.
Appendix
Available only for authorised users
Literature
go back to reference Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396–2402CrossRefPubMed Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396–2402CrossRefPubMed
go back to reference Churg A, Dai J, Tai H, Xie CS, Wright JL (2002) Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care 166:849–854. doi:10.1164/rccm.200202-097OC CrossRef Churg A, Dai J, Tai H, Xie CS, Wright JL (2002) Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care 166:849–854. doi:10.​1164/​rccm.​200202-097OC CrossRef
go back to reference Ding GX, Shao JL, Ding Q, Fang ZJ, Wu Z, Xu JF, Gao P (2012) Comparison of the characteristics of mesenchymal stem cells obtained from prostate tumors and from bone marrow cultured in conditioned medium. Exp Ther Med 4:711–715. doi:10.3892/etm.2012.642 PubMedPubMedCentral Ding GX, Shao JL, Ding Q, Fang ZJ, Wu Z, Xu JF, Gao P (2012) Comparison of the characteristics of mesenchymal stem cells obtained from prostate tumors and from bone marrow cultured in conditioned medium. Exp Ther Med 4:711–715. doi:10.​3892/​etm.​2012.​642 PubMedPubMedCentral
go back to reference Fritz V et al (2011) Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential. J Cell Biochem 112:3234–3245. doi:10.1002/jcb.23258 CrossRefPubMed Fritz V et al (2011) Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential. J Cell Biochem 112:3234–3245. doi:10.​1002/​jcb.​23258 CrossRefPubMed
go back to reference Ge C, Cawthorn WP, Li Y, Zhao G, Macdougald OA, Franceschi RT (2016) Reciprocal control of osteogenic and adipogenic differentiation by ERK/MAP kinase phosphorylation of Runx2 and PPARgamma transcription factors. J Cell Physiol 231:587–596. doi:10.1002/jcp.25102 CrossRefPubMed Ge C, Cawthorn WP, Li Y, Zhao G, Macdougald OA, Franceschi RT (2016) Reciprocal control of osteogenic and adipogenic differentiation by ERK/MAP kinase phosphorylation of Runx2 and PPARgamma transcription factors. J Cell Physiol 231:587–596. doi:10.​1002/​jcp.​25102 CrossRefPubMed
go back to reference Hossain A et al (2015) Mesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathway. Stem Cells 33:2400–2415. doi:10.1002/stem.2053 CrossRefPubMed Hossain A et al (2015) Mesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathway. Stem Cells 33:2400–2415. doi:10.​1002/​stem.​2053 CrossRefPubMed
go back to reference Martin FT et al (2010) Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 124:317–326. doi:10.1007/s10549-010-0734-1 CrossRefPubMed Martin FT et al (2010) Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 124:317–326. doi:10.​1007/​s10549-010-0734-1 CrossRefPubMed
go back to reference Muraglia A, Cancedda R, Quarto R (2000) Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113(Pt 7):1161–1166PubMed Muraglia A, Cancedda R, Quarto R (2000) Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113(Pt 7):1161–1166PubMed
go back to reference Neri S et al (2015) Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts. J Cancer Res Clin Oncol. doi:10.1007/s00432-015-2046-7 Neri S et al (2015) Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts. J Cancer Res Clin Oncol. doi:10.​1007/​s00432-015-2046-7
go back to reference Okamoto T et al (2002) Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 295:354–361CrossRefPubMed Okamoto T et al (2002) Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 295:354–361CrossRefPubMed
go back to reference Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620CrossRefPubMed Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620CrossRefPubMed
go back to reference Sugimoto H, Mundel TM, Kieran MW, Kalluri R (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5:1640–1646CrossRefPubMed Sugimoto H, Mundel TM, Kieran MW, Kalluri R (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5:1640–1646CrossRefPubMed
go back to reference Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778–784. doi:10.1038/ncb0901-778 CrossRefPubMed Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778–784. doi:10.​1038/​ncb0901-778 CrossRefPubMed
go back to reference Tu B, Peng ZX, Fan QM, Du L, Yan W, Tang TT (2014) Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-beta/Smad2/3 pathway. Exp Cell Res 320:164–173. doi:10.1016/j.yexcr.2013.10.013 CrossRefPubMed Tu B, Peng ZX, Fan QM, Du L, Yan W, Tang TT (2014) Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-beta/Smad2/3 pathway. Exp Cell Res 320:164–173. doi:10.​1016/​j.​yexcr.​2013.​10.​013 CrossRefPubMed
go back to reference Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci-Landmark 15:166–179. doi:10.2741/3613 CrossRef Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci-Landmark 15:166–179. doi:10.​2741/​3613 CrossRef
go back to reference Yan XL et al (2012) Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 132:153–164. doi:10.1007/s10549-011-1577-0 CrossRefPubMed Yan XL et al (2012) Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 132:153–164. doi:10.​1007/​s10549-011-1577-0 CrossRefPubMed
Metadata
Title
Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration
Authors
Yoshitaka Suda
Shinya Neri
Hiroko Hashimoto
Youichi Higuchi
Masayuki Ishibashi
Masato Sugano
Kenkichi Masutomi
Masahiro Tsuboi
Atsushi Ochiai
Genichiro Ishii
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 7/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2171-y

Other articles of this Issue 7/2016

Journal of Cancer Research and Clinical Oncology 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.